Zinc (zinc gluconate) NDC 49035-881

NDC codes

FDA NDC Directory

Product NDC (as listed)49035-881Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49035-0881Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
49035-881-25	49035088125	25 TABLET in 1 BOTTLE, PLASTIC (49035-881-25)Marketed from Oct 30, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zinc
Generic name (nonproprietary): zinc gluconate
Active ingredients: Zinc gluconate — 1 [hp_X]/1
Dosage form: Tablet
Route: Oral
Labeler: Wal-Mart Stores,Inc.,
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Oct 30, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Copper Ion Absorption (Physiologic effect)
Identifiers: Product ID 49035-881_4221f075-943c-26a6-e063-6294a90a4990SPL ID 4221f075-943c-26a6-e063-6294a90a4990SPL set ID ef4d82f6-2b77-41cd-9f4a-86ca9906a00dUNII U6WSN5SQ1ZUPC 0681131228428
Pharmacologic class: Copper Absorption Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N449035088125 followed by a unit qualifier and the quantity

Package 49035-0881-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 27, 2025.

Indications (excerpt from the label)

Uses may help reduce duration and severity of cold symptoms: sore throat stuffy nose sneezing coughing This product was formulated to help reduce the duration and severity of cold symptoms and was not formulated to be effective for flu or allergies.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)